Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent

Inclusion Criteria: * Patients ≥ 18 year-old. * A total occlusion (TIMI 0-1) with an estimated time of occlusion \> 2 weeks. * Symptomatic or silent ischaemia, or viable myocardium. * The occlusion is suitable for percutaneous coronary intervention. * The guidewire has crossed the occlusion, and the occlusion has been dilated with balloon or other device. Exclusion Criteria: * Acute myocardial infarction in the myocardial area supplied by the target vessel within 2 weeks before the inclusion in the study. * The lesion can not be crossed with the guidewire and balloon angioplasty. * The vessel has been previously treated percutaneously. * The lesion is not suitable for a 2.25-3.5 coronary stent implantation. * The patient is not willing to undergo an angiographic follow-up. * The patient has contraindications for prolonged double (aspirin plus clopidogrel) anti-platelet therapy (e.g. allergy to aspirin, need for chronic oral anti-coagulation, or scheduled surgical intervention within 12 months. * Pregnancy or absence of pregnancy test in women of childbearing age. * Chronic renal failure (creatinine plasmatic values \> 3.0 mg/dl). * Plasmatic platelet count \< 100.000 mm-3 or \> 700.000 mm-3. * The patient has a severe non-cardiac disease that limits his/her life expectancy to \< 1 year. * The patient is currently included in other randomized trial.